Tomás Egaña

Position
Associate Professor | Assistant Director of Graduate Studies
Academic unit
  • Institute of Biological and Medical Engineering UC
Lines of Research
  • Biomaterials
  • Tissue engineering
  • Developmental Biology
Summary

Associate Professor at the Institute of Biological and Medical Engineering (IIBM), Professor Tomás Egaña holds a PhD in Pharmacology from the University of Chile, a PhD in Human Biology from the University of Lübeck and a habilitation in Experimental Plastic Surgery from the Technical University of Munich.

His research has focused mainly on Regenerative Medicine and together with his research group
, he combines approaches in Biomaterials, Cellular and Molecular Therapy with the
development of new experimental models. One of his main contributions has been to "Photosynthetic Therapy".

Collaborations
- Hospital del Salvador
- Hospital del Trabajador
- Agrosuper Ltda.
Spin off: See
Google Scholar: See

  • 2003: Molecular Biotechnology Engineer, Universidad de Chile, Chile.
  • 2008: PhD in Biology. Universität zu Lübeck, Germany.
  • 2009: Doctor in Pharmacology. University of Chile.
  • 2016: Doctor Habilitatus in Experimental Plastic Surgery, TU München, Germany.

Current Projects

Fondecyt Regular Nr. 1240273 (2024-2029). "Enhancing the biomechanical properties of osteoporotic bones. A proof-of-concept study". Principal Investigator. Amount of financing: 234,227,000 CLP.

ANID Exploration Nr. 13220024 (2023- 2026). "Engineering oxygen-carrying photosynthetic microorganisms to improve oxygenation in animal tissues". Principal Investigator. Amount of financing: 271,920,000 CLP.

Fondef IDeA I+D Nr. ID24I10228 (2024-2026). "The use of photosynthetic microalgae to enhance the photodynamic properties of a bioactive hydrogel for the treatment of infected wounds: towards an alternative therapeutic approach against drug-resistant microorganisms". Principal Investigator. Funding amount: 227.700.000 CLP.

Seed fund with MIT (CoI). Amount of funding: 27,250 USD.

Previous Projects

CORFO Portfolio Nr. 18PIDE98887 (2018- 2022). "Development of a technological and commercial platform for the chronic wound treatment by photosynthetic oxygenation".

CORFO Contracts Nr. 18COTE-98070 (2018- 2020). "Development of a photosynthetic machine for
liver ex vivo for transplantation".

Fondecyt Regular Nr. 1160270 (2016- 2020). "The role of oxidative stress as a major effector of
cigarette smoke toxicity. A novel approach to develop bioactive filters for smokers".

CORFO Linea-2 Nr. 14IDL2-30154 (2015- 2017). "Development of a photosynthetic scaffold that
induce regeneration of non-healing chronic wounds".

This site is registered on wpml.org as a development site. Switch to a production site key to remove this banner.